Naloxone Hydrochloride Accord

Naloxone Hydrochloride, the active ingredient in Naloxone Hydrochloride Accord, is an opioid antagonist presented as a sterile injectable solution for intramuscular and intravenous use. It rapidly reverses the effects of opioid overdose and opioid‑induced respiratory depression in emergency settings.

GNH USA supplies Naloxone Hydrochloride Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution. Products are manufactured under EU GMP guidelines and undergo rigorous batch release testing to ensure safety and efficacy.

Naloxone Hydrochloride is an opioid antagonist used in emergency medicine to counteract opioid toxicity. - Opioid overdose: rapidly reverses life‑threatening respiratory depression, restores consciousness, and improves oxygenation in patients with suspected opioid intoxication. - Opioid‑induced respiratory depression: restores normal breathing and ventilation in patients receiving opioid analgesics who develop hypoventilation. - Opioid agonist toxicity: counteracts sedation, hypotension, and pinpoint pupils caused by opioid exposure, facilitating rapid clinical stabilization. - Post‑operative opioid respiratory depression: used to reverse excess opioid effects after surgery, ensuring safe recovery of breathing function.

Naloxone Hydrochloride may be associated with a range of adverse reactions, most of which are related to its pharmacologic action or route of administration.

Common Side Effects: - Injection site pain - Nausea - Vomiting - Sweating

Serious or Rare Side Effects: - Pulmonary edema - Severe hypertension - Seizures - Anaphylaxis

When using Naloxone Hydrochloride, clinicians should observe several precautionary measures to ensure safe and effective reversal of opioid effects. - Assess airway and breathing before administration: confirm need for opioid reversal. - Verify opioid overdose: ensure clinical suspicion before giving naloxone. - Monitor vital signs after dosing: watch for recurrent respiratory depression. - Avoid repeated dosing unless medically indicated: limit to the minimum effective amount. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Naloxone Hydrochloride can interact with other medications; awareness of these interactions helps optimize patient management.

Major Interactions (Avoid): - Concurrent use with other opioid antagonists: may precipitate severe withdrawal symptoms. - Administration during acute coronary syndrome with high‑dose opioids: may reduce analgesic efficacy and require alternative pain control.

Moderate Interactions (Monitor Closely): - Co‑administration with benzodiazepines: additive central nervous system depression may persist after naloxone effect wanes. - Use with adrenergic agents (e.g., epinephrine): may cause hypertension; monitor blood pressure. - Combination with monoamine oxidase inhibitors: no direct interaction but hemodynamic changes should be observed.